Shahabadi Nahid, Amiri Sara
Department of Chemistry, Faculty of Science, Razi University, Kermanshah, Iran.
Department of Chemistry, Faculty of Science, Razi University, Kermanshah, Iran.
Spectrochim Acta A Mol Biomol Spectrosc. 2015 Mar 5;138:840-5. doi: 10.1016/j.saa.2014.10.104. Epub 2014 Nov 13.
The interaction of the drug pregabalin (S-3-(aminomethyl)-5-methylhexanoic acid) with CT-DNA was studied by using fluorescence spectroscopy, UV-Vis, CD, molecular docking study and viscometery. The fluorescence and UV absorption spectroscopy indicated that the drug interacted with CT-DNA in a groove binding mode. The binding constant and the number of binding sites were 5.6×10(4)Lmol(-1) and 0.96, respectively. The fluorimetric studies showed that the reaction between the drug and CT-DNA is exothermic (ΔH=33.11kJmol(-1); ΔS=48.84Jmol(-1)K(-1)). Furthermore, the drug does not induce any changes in DNA viscosity. Circular dichroism spectroscopy (CD) was employed to measure the conformational changes of CT-DNA in the presence of the drug, which verified the groove binding mode. The molecular modeling results illustrated that the drug binds to groove of DNA by relative binding energy of docked structure -21.9kJmol(-1).
采用荧光光谱法、紫外可见光谱法、圆二色光谱法、分子对接研究和粘度测定法,研究了药物普瑞巴林(S-3-(氨甲基)-5-甲基己酸)与CT-DNA的相互作用。荧光光谱和紫外吸收光谱表明,该药物以沟槽结合模式与CT-DNA相互作用。结合常数和结合位点数分别为5.6×10⁴Lmol⁻¹和0.96。荧光分析表明,药物与CT-DNA之间的反应是放热的(ΔH = 33.11kJmol⁻¹;ΔS = 48.84Jmol⁻¹K⁻¹)。此外,该药物不会引起DNA粘度的任何变化。采用圆二色光谱法(CD)测定了药物存在下CT-DNA的构象变化,证实了沟槽结合模式。分子模拟结果表明,该药物通过对接结构的相对结合能-21.9kJmol⁻¹与DNA沟槽结合。